Article
Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
Current pharmaceutical design - 1 Jan 2007
Lenato G M, Suppressa P, Giordano P, Guanti G, Guastamacchia E, Triggiani V, Amati L, Resta F, Covelli V, Jirillo E, Sabbà C
Abstract excerpt
Hereditary Haemorrhagic Telangiectasia (HHT) or Rendu-Osler-Weber syndrome is an autosomal dominant disease characterized by local angiodysplasia affecting different organism districts. From a clinical viewpoint, HHT patients suffer from epistaxis, mucocutaneous telangiectases and arteriovenous malformations in various organs. Mutations in two known genes (ENG and ALK1) account for the majority of HHT patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.